18 Mar, 2011 11:34 AM
ATL1101 for Prostate Cancer Update
As previously reported, Antisense Therapeutics Limited (ANP) is seeking to partner the further development of its second generation antisense compound - ATL...read more
21 Feb, 2011 11:29 AM
Final Preparations for ATL1103 Clinical Trial
Antisense Therapeutics Limited (ANP) is pleased to advise that final preparations are being made for the first human trial of ATL1103, the Compan...read more
08 Dec, 2010 04:56 PM
ATL1103 - Additional US Patent Granted
Antisense Therapeutics Limited (ASX:ANP) is pleased to advise that on 7 December, 2010 the United States Patent Office granted US patent 7,846,906 cover...read more